Showing results (741-750 of 1,013) with videos related to

Sort By:
Pageof 102
Nature Microbiology|November 21, 2018
A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virionsLeslie Goo, Kari Debbink, Nurgun Kose, et al.
Plos Pathogens|April 19, 2014
Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagementMelissa A Edeling, S Kyle Austin, Bimmi Shrestha, et al.
Cell Host & Microbe|November 16, 2018
Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in MiceAngela M Fowler, William W Tang, Matthew P Young, et al.
Nature Immunology|October 7, 2024
Optimization of the Irf8 +32-kb enhancer disrupts dendritic cell lineage segregationFeiya Ou, Tian-Tian Liu, Pritesh Desai, et al.
Cell Reports|February 7, 2019
Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in MiceVanessa Salazar, Brett W Jagger, Juthathip Mongkolsapaya, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamstersBaoling Ying, Tamarand L Darling, Pritesh Desai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2012
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virionsRuklanthi de Alwis, Scott A Smith, Nicholas P Olivarez, et al.
Journal of Virology|March 2, 2012
West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral responseAndrea Schuessler, Anneke Funk, Helen M Lazear, et al.
Science (New York, N.Y.)|September 10, 2020
De novo design of picomolar SARS-CoV-2 miniprotein inhibitorsLongxing Cao, Inna Goreshnik, Brian Coventry, et al.
Pageof 102